All Stories

  1. Renal Pelvic Anatomy Is Associated with Incidence, Grade, and Need for Intervention for Urine Leak Following Partial Nephrectomy
  2. Growth Kinetics and Short-Term Outcomes of cT1b and cT2 Renal Masses under Active Surveillance
  3. Is radical nephrectomy a legitimate therapeutic option in patients with renal masses amenable to nephron‐sparing surgery?
  4. Variation in performance of candidate surgical quality measures for muscle‐invasive bladder cancer by hospital type
  5. Editorial Comment
  6. MP46-18 COMPARISON OF TOXICITY BETWEEN SINGLE MODALITY RADIATION THERAPY AND COMBINED MODALITY RADIATION THERAPY AMONG LOW RISK PROSTATE CANCER PATIENTS
  7. MP65-19 PERFORMANCE OF PRIMARY RADICAL CYSTECTOMY AND RISK OF PATHOLOGIC UPSTAGING IN PATIENTS WITH STAGE I HIGH GRADE UROTHELIAL CARCINOMA OF THE BLADDER: A NATIONAL CANCER DATABASE ANALYSIS
  8. PD17-04 EXPERIENCE WITH ACTIVE SURVEILLANCE (AS) IN PATIENTS WITH RENAL MASS >4CM: ASSESSMENT OF GROWTH KINETICS AND OUTCOMES
  9. PD17-05 TUMOR ANATOMIC COMPLEXITY PREDICTS GROWTH KINETICS OF RENAL MASSES UNDER ACTIVE SURVEILLANCE
  10. MP78-10 PURE AND DOMINANT GLEASON PATTERN 3 PROSTATE CANCER HAS LIMITED INVASIVE AND METASTATIC POTENTIAL
  11. MP30-19 LYMPHOPENIA IS AN INDEPENDENT PREDICTOR OF INFERIOR SURVIVAL IN PAPILLARY RENAL CELL CARCINOMA.
  12. MP59-07 PATIENTS WITH ANATOMICALLY “SIMPLE” RENAL MASSES ARE MORE LIKELY TO BE PLACED ON ACTIVE SURVEILLANCE THAN THOSE WITH ANATOMICALLY “COMPLEX” LESIONS
  13. MP2-04 EVALUATION OF THE ACS NSQIP SURGICAL RISK CALCULATOR IN PATIENTS UNDERGOING RADICAL CYSTECTOMY
  14. MP22-13 HOW SAFE IS EXTENDED PHARMACOLOGICAL VENOUS THROMBOEMBOLISM PROPHYLAXIS (EPVTEP) FOR PATIENT UNDERGOING RADICAL CYSTECTOMY?
  15. MP59-05 VALIDATION OF THE RENAL PELVIC SCORE: A NOVEL MARKER OF RENAL PELVIC ANATOMY THAT PREDICTS URINE LEAK FOLLOWING PARTIAL NEPHRECTOMY
  16. MP29-04 GAIN OF CHROMOSOME 8Q IS ASSOCIATED WITH INFERIOR SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA
  17. Impact of Folate Intake on Prostate Cancer Recurrence Following Definitive Therapy: Data from CaPSURE™
  18. Assessing the Burden of Complications After Surgery for Clinically Localized Kidney Cancer by Age and Comorbidity Status
  19. MP22-15 NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR): PROGNOSTIC INDICATOR FOR OVERALL SURVIVAL (OS) IN PATIENTS UNDERGOING RADICAL CYSTECTOMY (RC)
  20. MP40-06 MOST CYTOGENETICALLY PROVEN RENAL ONCOCYTOMAS AND CHROMOPHOBE CARCINOMAS CAN BE DIFFERENTIATED BY ROUTINE H&E AND CYTOKERATIN 7 STAINS ALONE
  21. Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal Biopsy
  22. Renal Cell Carcinoma: Management in the Elderly
  23. Splenogonadal Fusion: A Rare Etiology of Solid Testicular Mass
  24. Reply
  25. Obesity Is Not Associated With Aggressive Pathologic Features or Biochemical Recurrence After Radical Prostatectomy
  26. Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction in Infants
  27. 1805 PARTIAL NEPHRECTOMY IN THE SETTING OF ANTIPLATELET THERAPY: A MULTICENTER COMPARATIVE ANALYSIS
  28. 1790 RENAL PELVIC ANATOMY IS ASSOCIATED WITH URINE LEAK FOLLOWING OPEN PARTIAL NEPHRECTOMY
  29. 1791 ASSESSING THE BURDEN OF COMPLICATIONS FOLLOWING RENAL SURGERY IN ELDERLY AND COMORBID PATIENTS
  30. 1500 PROSTATE BIOPSY PERINEURAL INVASION IS NOT INDEPENDENTLY ASSOCIATED WITH POSITIVE SURGICAL MARGINS FOLLOWING OPEN RADICAL PROSTATECTOMY
  31. Editorial Comment
  32. Cloacal exstrophy variant with intravesical phallus: Further description of anatomy and implications for gender reassignment
  33. Comparative Hospital Cost-analysis of Open and Robotic-assisted Radical Prostatectomy
  34. Predictors of Immediate Postoperative Outcome of Single-tract Percutaneous Nephrolithotomy
  35. Pediatric Laparoscopic and Robot-Assisted Laparoscopic Surgery: Technical Considerations
  36. Upper Tract Urothelial Carcinoma: Current Treatment and Outcomes
  37. 1590 THE NOVEL OPIOID RECEPTOR ANTAGONIST ALVIMOPAN MINIMIZES POST-OPERATIVE ILEUS FOLLOWING RADICAL CYSTECTOMY
  38. Incidentally Discovered Osseous Metaplasia Within High-grade Urothelial Carcinoma of the Bladder
  39. 374 ONE YEAR UPDATED COMPARATIVE COST- ANALYSIS OF OPEN AND ROBOTIC-ASSISTED RADICAL PROSTATECTOMY
  40. Posterior Urethral Valves: Renal Failure and Prenatal Treatment
  41. Stone Cobras: Adult Bilateral Single System Ureteroceles Presenting With Multiple Calculi
  42. 155 AGGRESSIVE UROLOGIC MALIGNANCY IN HEART TRANSPLANT RECIPIENTS: 30-YEAR EXPERIENCE
  43. 777 COMPARATIVE COST-ANALYSIS OF ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY AND OPEN PROSTATECTOMY
  44. 629 PERCEPTION OF CLINICAL CHANGE IN THE EXPANDED PROSTATE INDEX COMPOSITE (EPIC) URINARY DOMAIN
  45. 128 GLOBAL DNA HYPOMETHYLATION MARKS A PROSTATE CANCER FIELD EFFECT
  46. 271 EXCESS DIETARY FOLATE INTAKE PROMOTES PROSTATE CARCINOGENESIS AND PROGRESSION IN AN IN VIVO MODEL OF TUMORIGENESIS
  47. Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate
  48. Management of Bladder Cancer following Solid Organ Transplantation
  49. Management of Urine Leak After Laparoscopic Cyst Decortication with Retrograde Endoscopic Fibrin Glue Application and Ureteral Stent Placement
  50. Renal Access by Urologist or Radiologist During Percutaneous Nephrolithotomy
  51. Emerging intravesical therapies for management of nonmuscle invasive bladder cancer
  52. 1455 RENAL ACCESS BY UROLOGIST OR RADIOLOGIST DURING PERCUTANEOUS NEPHROLITHOTOMY
  53. Outcomes of Percutaneous Nephrolithotomy Stratified by Body Mass Index
  54. 101 INCREASED CANCER CELL PROLIFERATION IN PROSTATE CANCER PATIENTS WITH HIGH LEVELS OF SERUM FOLATE
  55. Factors Affecting Blood Loss During Percutaneous Nephrolithotomy Using Balloon Dilation in a Large Contemporary Series
  56. Laparoscopic Retroperitoneal Lymph Node Dissection for High-Risk Pediatric Patients with Paratesticular Rhabdomyosarcoma
  57. Effect of Carbohydrate-Electrolyte Sports Beverages on Urinary Stone Risk Factors
  58. The Application of Endoscopic Techniques in the Management of Upper Tract Recurrence After Cystectomy and Urinary Diversion
  59. OUTCOMES OF PERCUTANEOUS NEPHROLITHOTOMY USING BALLOON DILATION IN A LARGE CONTEMPORARY SERIES
  60. Endourologic Management of Upper Tract Transitional Cell Carcinoma following Cystectomy and Urinary Diversion
  61. Staged endourologic and endovascular repair of an infrarenal inflammatory abdominal aortic aneurysm presenting with forniceal rupture